Back to search
FDAFDA · Food and drugs·Recall number Z-0682-2019

ABL800 analyzer, model numbers 393-800 and 393-801.

Published January 2, 2019 · Recall initiated: July 3, 2018

Summary

FDA records medical device Class II recall Z-0682-2019, published January 2, 2019 and initiated July 3, 2018. Recalling firm: Radiometer America Inc; Status: Terminated; Reported quantity: 2,131 analyzers; Lot: Model 393-800 ABL800 Series w/o Creatinin (All serial numbers) for the following configurations: ABL800, ABL805, ABL810, ABL815, ABL820, ABL825, ABL830, and ABL835. Model 393-801 ABL800 Series with Creatinin (All serial numbers) for the following configurations: ABL817, ABL827, and ABL837. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The analyzer software may cause a mis-match of patient demographics and test results when a certain sequence of events occur.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Radiometer America Inc
Distributor
Distribution was nationwide. There was also military/government distribution. Foreign distribution was made to Canada.
Lot
Model 393-800 ABL800 Series w/o Creatinin (All serial numbers) for the following configurations: ABL800, ABL805, ABL810, ABL815, ABL820, ABL825, ABL830, and ABL835. Model 393-801 ABL800 Series with Creatinin (All serial numbers) for the following configurations: ABL817, ABL827, and ABL837.
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was ABL800 analyzer, model numbers 393-800 and 393-801. recalled?

Yes. FDA published recall Z-0682-2019 on January 2, 2019. Reported hazard: The analyzer software may cause a mis-match of patient demographics and test results when a certain sequence of events occur.

What should I do if I have this product?

Voluntary: Firm initiated · Letter